secwatch.observer — SEC 8-K summary
======================================

Issuer:     NEPHROS INC (NEPH)
CIK:        0001196298
Form:       8-K
Filed at:   2024-11-13T23:59:59+00:00
Accession:  0001493152-24-045135
Event type: earnings
Sentiment:  positive
Materiality: 0.65
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Nephros posts Q3 net income of $0.2M, first profitable quarter; revenue $3.5M
-----------------------------------------------------------------------------

- Net revenue $3.5M, down 6% YoY but up 8% from Q2 2024.
- Net income $0.2M vs net loss $0.2M in Q3 2023; first profitable quarter.
- Adjusted EBITDA $295K vs $11K; gross margin improved to 61% from 59%.
- Cash $2.5M as of Sep 30, 2024, down from $4.3M at Dec 31, 2023.
- CEO cites South Central region underperformance and slower ordering from large accounts.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1196298/000149315224045135/0001493152-24-045135-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1196298/000149315224045135/form8-k.htm
  HTML page:      https://secwatch.observer/filing/0001493152-24-045135

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer